Neuronal metabolic and methylation pathways

Neuronal metabolic and methylation pathways refer to the integrated biochemical systems, primarily one-carbon metabolism, that regulate cellular energy and epigenetic signaling in the brain (Fuso & Scarpa, 2011). These pathways involve the folate and methionine cycles, which generate S-adenosylmethionine (SAM), the essential methyl donor for DNA, RNA, protein, and neurotransmitter methylation (Miller, 2008). Proper functioning of these pathways is critical for neuronal development, synaptic plasticity, and the maintenance of the myelin sheath. Dysregulation is a hallmark of several pathological states, including Alzheimer’s disease, where hypomethylation of certain genes can lead to increased amyloid-beta production (Coppedè, 2010). Pharmacological targeting of these pathways often involves the use of medical foods like L-methylfolate or supplements like SAMe to bypass metabolic blocks and restore methylation capacity (Stahl, 2008). Additionally, drugs like valproic acid can influence these pathways by acting as histone deacetylase inhibitors, indirectly affecting the epigenetic landscape (Detich et al., 2003). Because this term describes a broad set of interconnected enzymatic reactions rather than a single protein or receptor, it is classified as a biological pathway rather than a discrete therapeutic target. Monitoring biomarkers such as homocysteine and SAM levels is essential for assessing the functional status of these pathways in clinical settings.

Other names

One-carbon metabolismMethionine-folate cycleNeuronal epigenetic pathwaysCerebral methyl metabolism

Regulation of methyl group availability and transfer to biological substrates to modulate gene expression and neuronal metabolism.